Response by Unlu et al to Letter Regarding Article, "Polypharmacy in Older Adults Hospitalized for Heart Failure"
Circ Heart Fail
.
2021 Mar;14(3):e008305.
doi: 10.1161/CIRCHEARTFAILURE.121.008305.
Epub 2021 Mar 12.
Authors
Ozan Unlu
1
,
Emily B Levitan
2
,
Mathew S Maurer
3
,
Monika M Safford
4
,
Mark S Lachs
5
,
Parag Goyal
4
6
Affiliations
1
Department of Medicine (O.U.), Weill Cornell Medicine, New York, NY.
2
Department of Epidemiology, University of Alabama at Birmingham (E.B.L.).
3
Division of Cardiology, Columbia University Medical Center, New York, NY (M.S.M.).
4
Division of General Internal Medicine/Department of Medicine (M.M.S., P.G.), Weill Cornell Medicine, New York, NY.
5
Division of Geriatrics/Department of Medicine (M.S.L.), Weill Cornell Medicine, New York, NY.
6
Division of Cardiology/Department of Medicine (P.G.), Weill Cornell Medicine, New York, NY.
PMID:
33706544
PMCID:
PMC8451272
DOI:
10.1161/CIRCHEARTFAILURE.121.008305
No abstract available
Publication types
Letter
Comment
MeSH terms
Aged
Heart Failure* / diagnosis
Heart Failure* / drug therapy
Humans
Polypharmacy*
Grants and funding
R03 AG056446/AG/NIA NIH HHS/United States